WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in AVXL — Anavex Life Sciences Corp.

CIK 1632972 PLYMOUTH, MN

Position in AVXL

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$80,631

-$10,041 QoQ

Shares Held

31,132

+5.4% QoQ

Ownership

0.034%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 13 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 4% Shared 0% None 96%

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $166,117,226 across 147 Biotechnology names. AVXL ranks #114 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,889	$22,794,442
2	REGN	Regeneron Pharmaceuticals, Inc.	33,880	$21,125,535
3	INCY	Incyte Corp	151,505	$17,174,606
4	EXEL	Exelixis, Inc.	207,728	$11,302,480
5	RPRX	Royalty Pharma plc	179,888	$10,086,320
6	CORT	Corcept Therapeutics Inc	76,278	$6,632,372
7	HALO	Halozyme Therapeutics, Inc.	70,797	$5,541,281
8	AXSM	Axsome Therapeutics, Inc.	19,919	$4,875,573

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$80,631	31,132	+5.4%	Shares	Sole	2026-07-15
2026-03-31	$90,672	29,535	+102.9%	Shares	Sole	2026-04-08
2025-12-31	$51,808	14,553	+26.7%	Shares	Sole	2026-01-08
2025-09-30	$102,216	11,485	-33.6%	Shares	Sole	2025-10-29
2025-06-30	$159,552	17,305	-23.5%	Shares	Sole	2025-07-10
2025-03-31	$194,148	22,628	-15.2%	Shares	Sole	2025-04-16
2024-12-31	$286,468	26,673	+69.4%	Shares	Sole	2025-03-17
2024-09-30	$89,448	15,748	+8.6%	Shares	Sole	2024-10-24
2024-06-30	$61,198	14,502	+3.0%	Shares	Sole	2024-07-16
2024-03-31	$71,667	14,080	+10.1%	Shares	Sole	2024-04-15
2023-12-31	$119,084	12,791	+17.6%	Shares	Sole	2024-01-30
2023-09-30	$71,231	10,875	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.